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ㅋ
Noncardiac chest pain is defined as recurrent chest pain that is indistinguishable from ischemic heart pain after a reasonable 
workup has excluded a cardiac cause. Noncardiac chest pain is a prevalent disorder resulting in high healthcare utilization and 
significant work absenteeism. However, despite its chronic nature, noncardiac chest pain has no impact on patients’ mortality. 
The main underlying mechanisms include gastroesophageal reflux, esophageal dysmotility and esophageal hypersensitivity. 
Gastroesophageal reflux disease is likely the most common cause of noncardiac chest pain. Esophageal dysmotility affects only 
the minority of noncardiac chest pain patients. Esophageal hypersensitivity may be present in non-GERD-related noncardiac 
chest pain patients regardless if esophageal dysmotility is present or absent. Psychological co-morbidities such as panic dis-
order, anxiety, and depression are also common in noncardiac chest pain patients and often modulate patients’ perception of 
disease severity.
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Introduction
Noncardiac chest pain (NCCP) is very common in the gen-
eral population; however, a patient’s history and characteristics 
do not reliably distinguish between cardiac and esophageal causes 
of chest pain.
1,2 When it comes to chest pain, the cardiologist’s 
first priority is to exclude any acute life-threatening cardio-
vascular condition.
3 These include acute coronary syndrome, 
aortic dissection, pulmonary thromboembolism, and pericardial 
tamponade. If these acute conditions have been excluded, evalua-
tion for chronic ischemic heart disease or pericardial disease must 
be pursued. Various tests can help determine the presence and se-
verity of ischemia, left ventricular function, appearance of the 
coronary arteries, and functional capacity. They include exercise 
test electrocardiogram, echocardiography or nuclear single pho-
ton emission computed tomography (SPECT) and, if patients 
are unable to exercise, pharmacologic echocardiography, nuclear 
SPECT or cardiac MRI. The decision about which tests to pur-
sue should be left to the discretion of the treating cardiologist.
4 
The heightened awareness about the potentially devastating ram-
ifications of chest pain may drive patients to seek further medical Noncardiac Chest Pain
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attention despite a negative cardiac workup.
5
Compared to patients with cardiac angina, those with NCCP 
are usually younger, less likely to have typical symptoms, and 
more likely to have a normal resting electrocardiogram.
6 Additio-
nally, levels of anxiety of NCCP patients seen in a rapid access 
chest pain clinic significantly exceeded those of patients with car-
diac angina and remained above community norms for at least 2 
months after clinic visit.
7 NCCP patients view their condition as 
significantly less controllable and less understandable than those 
whose pain is of cardiac origin.
8
NCCP may be the manifestation of gastrointestinal (GI) or 
non-GI-related disorders. An important step toward under-
standing the underlying mechanisms of NCCP was the recog-
nition that gastroesophageal reflux disease (GERD) is the most 
common contributing factor for chest pain. While chest pain has 
been considered an atypical manifestation of GERD, it is an in-
tegral part of the limited repertoire of esophageal symptoms. In 
patients with non-GERD related NCCP, esophageal motility 
disorders, and functional chest pain (FCP) of presumed esoph-
ageal origin are the main underlying mechanisms for symptoms. 
The Rome III Committee does not specifically address NCCP 
but rather a subset of patients with NCCP termed “functional 
chest pain of presumed esophageal origin” to describe recurrent 
episodes of substernal chest pain of visceral quality with no appa-
rent explanation. As with all other functional esophageal dis-
orders, GERD and esophageal dysmotility should also be ruled 
out before the diagnosis is established.
9 However, up to 20% of 
patients with FCP exhibit other functional disorders, primarily 
irritable bowel syndrome (27%) and abdominal bloating (22%).
10
Definition
Noncardiac chest pain is defined as recurrent chest pain 
that is indistinguishable from ischemic heart pain after a 
reasonable workup has excluded a cardiac cause.
Patients with NCCP may report squeezing or burning sub-
sternal chest pain, which may radiate to the back, neck, arms and 
jaws, and is indistinguishable from cardiac related chest pain. 
This is compounded by the fact that patients with history of coro-
nary artery disease (CAD) may also experience NCCP. Conse-
quently, all NCCP patients should first undergo evaluation by a 
cardiologist to exclude cardiac angina.
11,12 Differentiating on a 
clinical basis only between cardiac angina and NCCP has been 
shown to be a very difficult task.
1 Furthermore, NCCP patients 
tend to report a higher rate of chest pain occurrence and greater 
pain intensity. They also  more use commonly sensory and affec-
tive words than patients with ischemic heart disease.
1 For the car-
diologist, any two of the following clinical characteristics are sug-
gestive of atypical cardiac angina and only one or none of these 
characteristics is indicative of NCCP: (1) substernal chest dis-
comfort, pressure or heaviness that lasts several minutes, (2) pain 
induced by exertion, emotion, exposure to cold or a large meal 
and (3) pain that is relieved by rest or nitroglycerine usually signi-
fy cardiac angina.
3
When it comes to chest pain, the cardiologist’s first priority is 
to exclude any acute life threatening cardiovascular condition.
3 
These include acute myocardial infarction, unstable angina, aortic 
dissection, pulmonary thromboembolism and pericardial tam-
ponade. If an acute cardiac syndrome has been excluded, then 
evaluation for chronic ischemic heart disease or pericardial dis-
ease should be pursued. Various tests can help determine the 
presence and severity of ischemia, left ventricular function, ap-
pearance of the coronary arteries and functional capacity. They 
include exercise electrocardiogram or exercise echocardiography, 
echocardiography or nuclear SPECT and, if patients are unable 
to exercise, pharmacologic (dobutamine, persantine or adeno-
sine) echocardiography, nuclear SPECT or cardiac MRI. The 
decision of which tests to pursue should be left to the discretion of 
the treating cardiologist.
4 A recent, population-based cohort 
study with nested case-control analysis demonstrated that patients 
with chest pain but without established ischemic heart disease had 
an increased risk of being diagnosed with ischemic heart disease 
(hazard ratio, 18.2; 95% CI, 11.6 to 28.6) in the year after the in-
dex event of chest pain.
13
We did not include frequency or severity of chest pain in our 
definition, because there is no clear spectrum or threshold of both 
clinical parameters in the literature. As a result, any attempt to 
limit the frequency and/or severity of chest pain may exclude 
many true sufferers with NCCP.
There are many causes for NCCP, and they are not limited to 
the esophagus (Table 1). Thus, the term NCCP is more inclusive 
and includes musculoskeletal, pulmonary, cardiovascular, in-
fectious, drug-related, psychological and other GI disorders.
14 
Our focus in these guidelines will be only on esophageal-related 
mechanisms for NCCP. The Rome Criteria do not specifically 
address NCCP but rather a subset of patients with NCCP 
termed FCP of presumed esophageal origin.
9 These are patients 
with recurrent episodes of substernal chest pain of visceral quality 
with no apparent explanation using currently available tests.Ronnie Fass and Sami R Achem
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Table 1. Common Noncardiac, Nonesophageal Etiologies for Chest Pain 
Musculoskeletal
Tietze’s syndrome
Costochondritis
Fibromyalgia
Precordial catch syndrome
Slipping rib syndrome
Gastrointestinal
Gastric 
Biliary tree
Pancreatic
Intra-abdominal masses (benign and malignant)
Pulmonary
Pneumonia
Pulmonary embolus
Lung cancer
Sarcoidosis
Pneumothorax and pneumomediastinum
Pleural effusions
Intrathoracic masses (benign and malignant)
Miscellaneous
Aortic disorders
Pericarditis and myocarditis
Pulmonary hypertension
Herpes zoster
Drug-induced pain
Sickle cell crisis
Psychological disorders
Epidemiology
Noncardiac chest pain is a prevalent disorder resulting in 
high healthcare resource utilization and significant work 
absenteeism.
Information about the epidemiology of NCCP in the United 
States and around the world is relatively limited. Presently, chest 
pain is the second most common presentation to hospital emer-
gency departments; however, only 25% of individuals who expe-
rience chest pain actually present to a hospital.
15
The mean annual prevalence of NCCP in 6 population- 
based studies was approximately 25%. However, these studies 
differ in many aspects such as NCCP definition, geography, 
sample size, sampling order and ethnic disparities.
16 A pop-
ulation-based survey in the United States assessed the prevalence 
of GERD in Olmsted County, Minnesota and reported an over-
all NCCP prevalence of 23%.
17 Gender distribution among 
NCCP patients was similar (24% among males and 22% among 
females). Using the Rome criteria for functional GI disorders, 
Drossman et al
18 reported a prevalence of 13.6% in 8,250 house-
holds in the United States. In this study, FCP of presumed 
esophageal origin was diagnosed rather than NCCP. Eslick et 
al
19,20 recently evaluated the prevalence of NCCP in Australia by 
using a mailing of a validated Chest Pain Questionnaire to 1,000 
randomly selected individuals. The study demonstrated a preva-
lence rate of 33% with almost equal gender distribution (32% in 
males versus 33% in females). This study also showed that the 
population prevalence of NCCP decreases with increasing 
age.
19,20
A nationwide population-based study from South America 
found that the annual prevalence of NCCP was 23.5% and that 
NCCP has been equally reported by both sexes.
21 In this study, 
frequent typical GERD symptoms (at least once a week) were 
significantly and independently associated with NCCP. Another 
recently published epidemiologic study demonstrated that the an-
nual prevalence of NCCP in a Chinese population was 19%.
22
Although females with NCCP tend to consult healthcare 
providers more often than men, the disorder affects both sexes 
equally.
17,19,21 Additionally, females are more likely to present to 
hospital emergency departments with NCCP than males, but 
there are no sex differences regarding chest pain intensity.
23 
Overall, women tend to use terms like “burning” and “frighte-
ning” more often than men.
24
Epidemiologic studies report a decrease in the prevalence of 
NCCP with increasing age. Women under 25 years of age and 
those between 45 and 55 years of age have the highest prevalence 
rates.
20 Patients with NCCP are younger, consume greater 
amounts of alcohol and tobacco, and are more likely to suffer 
from anxiety than their counterparts with ischemic heart disease. 
Patients with NCCP continue to seek treatment on a regular ba-
sis after the diagnosis was established for both chest pain and oth-
er unrelated symptoms, but few are in contact with hospital 
services.
25
In 1 study, almost a fourth of individuals with NCCP had 
sought healthcare for chest pain within the previous 12 months. 
None of the GI (heartburn, dysphagia and acid regurgitation) or 
psychological (anxiety, depression and neuroticism) risk factors 
was significantly associated with pursuing consultation for 
NCCP.
20
A recent US-based survey revealed that cardiologists manage 
by themselves about half of the patients who are diagnosed with 
NCCP.
26 Of those NCCP patients who were referred, 45.9% 
were sent back to the primary care physician (PCP), and only 
29.3% to a gastroenterologist. In a survey of PCPs, Wong et al
27 
demonstrated that most NCCP patients were diagnosed and 
treated by PCPs (79.5%) without being referred to a gas-
troenterologist. The most preferred subspecialty for the initial di-Noncardiac Chest Pain
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agnostic evaluation of a patient presenting with chest pain was 
cardiology (62%), followed by gastroenterology (17%). The 
mean percentage of such referrals was only 22%. The most pre-
ferred subspecialty for further management of NCCP was gas-
troenterology (76%), followed by cardiology (8%). The mean 
percentage of the actual referral rate was 29.8% for gastro-
enterologists and 14% for cardiologists.
27
A study by Eslick and Talley
28 reported that 78% of patients 
who presented to a hospital emergency department with acute 
chest pain had seen a healthcare provider in the last 12 months. 
The most common healthcare provider seen was a general practi-
tioner (85%), followed by cardiologist (74%), gastroenterologist 
(30%), pulmonologist (14%), alternative therapist (8%) and psy-
chologist (10%).
28 A multiple logistic regression analysis revealed 
that patients with chest pain who are also suffering from heart-
burn were 16 times more likely to see a general practitioner (OR, 
16.40; 95% CI, 1.98-135.99) and 3 times more likely to consult a 
gastroenterologist (OR, 3.10; 95% CI, 1.26-7.62). Additionally, 
work absenteeism rates (29%) and interruptions to daily activities 
(63%) were high because of NCCP.
Many patients with NCCP report poor quality of life and ad-
mit taking cardiac medications despite lack of evidence for a car-
diac cause. Only a small fraction of patients feel reassured. Con-
sequently, the economic burden of the disease has been proposed 
to be very high, although studies evaluating the cost impact of 
NCCP on the healthcare system are very scarce. In 1 study, the 
healthcare cost for NCCP was estimated to be more than $315 
million annually, primarily because of multiple clinic visits, emer-
gency room visits, hospitalizations and prescription medications.
29 
This cost estimate does not include indirect costs such as lost days 
of work or the impact of symptoms on patients’ quality of life, 
which have been demonstrated to be more significant when eval-
uating the economic burden of patients with functional bowel 
disorders. In Australia, the annual cost associated with NCCP 
presentations to the Nepean Hospital amount to approximately a 
$1.4 million.
30 The researchers extrapolated these costs to the 
Australian healthcare system and conservatively estimated that 
NCCP accounts for at least a $30 million of the healthcare budget 
annually.
Natural Course
Noncardiac chest pain is a chronic disorder that reduces 
patient's quality of life but has no impact on mortality.
Thus far, very few studies have evaluated the natural course 
of NCCP. Obviously, the main concern is the likelihood of these 
patients developing true ischemic heart disease if followed long 
term. One of the early studies by Wielgosz et al
31 followed 821 
patients with chest pain and normal coronary arteries for a period 
of 1-year. The authors demonstrated that only 3 (0.3%) patients 
died, and all were due to nonischemic reasons.
31 However, most 
of the patients (67%) continued to experience chest pain to some 
degree (39% less pain, 26% the same pain and 2% more severe 
pain). In a study that followed 46 NCCP patients over a period of 
11 years, only 2 (4.3%) of the subjects died from a cardiovascular- 
related event (stroke and ischemic heart disease). Again, as in the 
previous study, 74% of the surviving NCCP patients continued 
to report chest pain 11 years later, and of those 34% reported 
chest pain symptoms weekly.
32 Other studies also documented a 
very limited long-term mortality in NCCP patients but with con-
tinuous debilitating symptoms, impaired functional status, chronic 
use of drugs (GI, cardiac and psychiatric), repeated admissions to 
the hospital, and repeated cardiac and noncardiac proce-
dures.
25,33-37 In a survey study, 119 NCCP patients, of which 63 
were diagnosed as having pain from the esophagus, were followed 
for a period of 21.8-month.
38 Patients with esophageal-related 
chest pain usually continued to have recurrent pain. Interestingly, 
a specific diagnosis did not significantly increase the likelihood of 
pain resolution. However, patients who understood that the 
esophagus was the source of their pain were significantly less like-
ly to feel disabled by their pain and therefore were less likely to re-
quire continued physician evaluation. This study was published 
prior to the proton pump inhibitor (PPI) era. It is unlikely that 
patients with NCCP due to GERD will continue to have symp-
toms long term if they are compliant with their antireflux 
treatment. In another study that compared long-term natural his-
tory between NCCP and GERD patients, the authors found no 
significant difference in survival between the 2 groups (hazard 
ratio, 1.1; 95% CI, 0.8-1.5). Interestingly, the diagnosis of NCCP 
disappeared from the electronic hospital record in 96% of the pa-
tients within 2 years of follow-up.
39
In a recent study that followed 355 NCCP patients, the au-
thors demonstrated that 49% sought care in the emergency de-
partment, 42% underwent repeated cardiac workup, and only 
15% were seen by a gastroenterologist.
13 Survival free of cardiac 
death in the subset with NCCP and a GI disorder was 90.2% at 
10 years and 84.8% at 20 years, compared to 93.7% at 10 years 
and 88.1% at 20 years for those with NCCP of unknown origin.
Less than a handful of studies reported similar mortality be-
tween patients with NCCP and those with CAD.
37,40 A more re-Ronnie Fass and Sami R Achem
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cent study by Eslick and Talley
41 followed 126 NCCP and 71 
cardiac patients who were seen in the emergency room for a peri-
od of 4-year. The majority of the NCCP (71%) and the CAD pa-
tients (81%) continued to have symptoms 4 years later. The au-
thors found no difference in the mortality rate between the 2 
groups (CAD-11.0% vs NCCP-5.5%, P = 0.16). However, the 
study may suffer from type II error, and the results need to be 
confirmed in a larger cohort of patients.
Overall, the aforementioned data support the overall con-
clusion that increased mortality is uncommon in NCCP patients. 
However, patients with NCCP demonstrate poor quality of life 
primarily due to continuation of symptoms many years after 
diagnosis.
Pathogenesis
Gastroesophageal Reflux Disease
Gastroesophageal reflux disease is the most common 
esophageal cause for noncardiac chest pain in patients 
with and without coronary artery disease.
   Many studies have shown an association between GERD 
and NCCP. However, association does not confer causality. 
Resolution or improvement of chest pain symptoms in response 
to treatment with antireflux medications provides the missing 
causal link.
Locke et al and colleagues
17 have demonstrated that NCCP 
is more commonly reported by patients (37%) who experience 
heartburn symptoms at least weekly, as compared with 30.7% of 
those who have infrequent heartburn (less than once a week) and 
7.9% of those without any GERD symptoms. In another com-
munity-based study, the authors found that 53% of all patients 
with NCCP experienced heartburn and 58% acid regurgita-
tion.
20 Stahl et al
42 found in a small sample of NCCP patients that 
61.5% had GERD-related symptoms. In 3 different studies eval-
uating the role of the PPI test in patients with NCCP, the au-
thors found GERD-related symptoms in 68%-90% of the 
patients.
43-45
Ambulatory 24 hour esophageal pH testing studies have 
demonstrated that about half of NCCP patients have an abnor-
mal esophageal acid exposure. Stahl et al
42 evaluated 13 consec-
utive NCCP patients and found that 69.2% had an abnormal pH 
test. Beedassy et al
46 evaluated 104 patients with NCCP and 
documented that 48% of them had an abnormal pH test. It 
should be noted that only 21% of the 52 patients who reported 
chest pain during the study had a concomitant acid reflux event. 
Interestingly, only 10 of the 52 subjects had a positive symptom 
index (＞ 50%). Similarly, DeMeester et al
47 demonstrated that 
46% of patients with chest pain had symptoms associated with an 
acid reflux event as documented during pH testing. Pandak et 
al
48 found an abnormal pH test in 42% of NCCP patients. In 3 
different studies evaluating the role of the PPI test, the authors 
found abnormal pH test in 37.5%-67% of the NCCP pa-
tients.
43-45 In a study from Asia, 34.3% of the NCCP patients had 
at least 1 abnormal pH parameter.
49 Even in patients with CAD 
who continued to have atypical chest pain symptoms, up to 67% 
had some of their painful episodes associated with acid reflux.
50
The presence of esophageal mucosal abnormalities consistent 
with GERD appears to be less common in NCCP patients than 
GERD symptoms or excess esophageal acid exposure. From dif-
ferent studies, the range has been between 2.5%-75%.
14,49,51,52 In 
3 different studies evaluating the role of the PPI test in patients 
with NCCP, the authors found GERD-related endoscopic find-
ings in 44%-75% of the NCCP patients.
43-45 In all of these studies, 
low-grade erosive esophagitis was the main GERD-related endo-
scopic finding. A recent study by Dickman et al
53 evaluated up-
per GI findings in patients with NCCP as compared with those 
having only GERD-related symptoms using a large multicenter 
consortium. Of the NCCP group, 28.6% had hiatal hernia, 
19.6% erosive esophagitis, 4.4% Barrett’s esophagus, and 3.6% 
esophageal stricture/stenosis (Table 2). The prevalence of these 
findings was significantly lower in the NCCP group when com-
pared with the GERD group. From this study, it appears that 
GERD-related mucosal abnormalities are not uncommon in the 
esophagus of NCCP patients. However, the prevalence of these 
a n a tom ica l fin d in gs  is  lo w er tha n  w h a t ha s  been  ob serv ed  in 
GERD patients. Importantly, NCCP patients may also demon-
strate Barrett’s esophagus, albeit uncommonly.
The mechanism by which gastroesophageal reflux causes 
NCCP remains poorly understood. It is still unclear why esoph-
ageal exposure to gastric content in some patients causes heart-
burn and in others chest pain. This is compounded by the fact 
that some patients may experience chest pain at 1 time and heart-
burn at other times.
Characteristics of the individual reflux episodes (duration 
and pH level) have been proposed to influence patients’ symp-
toms. Smith et al
54 studied 25 individuals with NCCP to de-
termine the relation between the sensation of pain in GERD and 
pH of the refluxate. They found that all 25 patients had re-
production of their pain during intraesophageal infusion of sol-Noncardiac Chest Pain
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Table 2. The Value of Endoscopy in Noncardiac Chest Pain Patients From a 
Large Multicenter Consortium
Findings Chest pain group
(n= 3,688) 
Reflux group
(n = 32,981) P-value
Barrett’s esophagus   163 (4.4%) 3,016 (9.1%) ＜0.0001
Esophageal inflammation   715 (19.4%) 9,153 (27.8%) ＜0.0001
Hiatal hernia 1,053 (28.6%) 14,775 (44.8%) ＜0.0001
Normal 1,627 (44.1%) 12,801 (38.8%) ＜0.0001
Stricture/stenosis   132 (3.6%) 1,223 (3.7%)     0.69
utions with pH 1 and 1.5. Reflux events resulting in pain were 
significantly longer than those without pain and were more often 
associated with a recently preceding painful episode.
Different underlying mechanisms have been suggested to re-
sult in esophageal hypersensitivity in NCCP patients. These in-
clude peripheral sensitization of esophageal sensory afferents 
leading to heightened responses to physiologic and pathologic 
stimuli and modulation of afferent neural function at the level of 
the spinal dorsal root or the central nervous system.
55 In 1 
study,
56 healthy subjects underwent perfusion of the distal esoph-
agus with normal saline or 0.1 N hydrochloric acid. Perceptual 
responses to intraluminal esophageal balloon distension were 
evaluated using electronic barostat. As compared with saline, acid 
perfusion reduced the perception threshold (innocuous sensa-
tion) and tended to reduce the pain threshold (aversive sensa-
tion). This study demonstrated short-term sensitization of me-
chanosensitive afferent pathways by transient exposure to acid. 
The authors suggested that in patients with NCCP, acid reflux 
induces sensitization of the esophagus, which may subsequently 
alter the way the esophagus perceives otherwise normal esoph-
ageal distentions. Sarkar et al
57 recruited 19 healthy volunteers 
and 7 patients with NCCP. Hydrochloric acid was infused into 
the distal esophagus over 30 minutes. Sensory responses to elec-
trical stimulation were monitored within the acid-exposed distal 
esophagus and the non-exposed proximal esophagus before and 
after infusion. In the healthy subjects, acid infusion into the distal 
esophagus lowered the pain threshold in the upper esophagus. 
Patients with NCCP already had a lower resting esophageal pain 
threshold than healthy subjects. After acid perfusion, their pain 
threshold in the proximal esophagus fell further and for a longer 
duration than was the case for the healthy subjects. Additionally, 
there was a decrease in pain threshold after acid infusion in the 
anterior chest wall. This study demonstrated the development of 
secondary allodynia (visceral hypersensitivity to innocuous stim-
ulus in normal tissue that is in proximity to the site of tissue in-
jury) in the proximal esophagus by repeated acid exposure of the 
distal esophagus. The concurrent visceral and somatic pain hy-
persensitivity is most likely caused by central sensitization (an in-
crease in excitability of spinal cord neurons induced by activation 
of nociceptive C-fibers in the area of tissue injury). The patients 
with NCCP demonstrated visceral hypersensitivity and amplified 
secondary allodynia in the esophagus. 
Another explanation how GERD may cause chest pain was 
provided by studies using high-frequency, intraluminal ultra-
sonography. Balaban et al
58 demonstrated a temporal correlation 
between sustained contractions of the esophageal longitudinal 
muscle and spontaneous as well as provoked esophageal chest 
pain. In a follow-up study, the authors suggested that the dura-
tion of sustained esophageal contraction determines the type of 
symptom perceived by patients.
59 Heartburn was associated with 
shorter duration contractions, whereas chest pain was associated 
with contractions of longer duration. In a recent study, the au-
thors suggested that esophageal muscle thickness per se, in the 
absence of esophageal motility abnormality, can lead to chest pain 
symptoms.
60
Studies have demonstrated that NCCP patients with evi-
dence of GERD (endoscopic findings and/or abnormal pH test) 
commonly respond to antireflux treatment. Between 78%-92% of 
NCCP patients with objective evidence of GERD demonstrated 
symptoms improvement on antireflux treatment.
43,45,48,49 In con-
trast, response to PPI treatment in NCCP patients without ob-
jective evidence of GERD ranged between 10% and 14%.
43-45  It 
Kushnir et al
61 have demonstrated that a positive symptom-asso-
ciation probability and elevated acid exposure time predicted re-
sponse to PPI treatment in patients with NCCP. When used hi-
erarchically, response to antireflux treatment was best predicted 
when GERD parameters (acid exposure time, symptom-associa-
tion probability and symptom index) were all abnormal and poor-
est when all normal. These data suggest a causal relationship be-
tween patients’ GERD and chest pain symptoms.
Esophageal Motility
Only the minority of patients with noncardiac chest pain 
demonstrate esophageal motility abnormalities.
Several large studies demonstrated that approximately 30% 
of NCCP patients had abnormal esophageal manometry.
62-64 In 1 
study that included 910 NCCP patients, the authors found that 
70% had normal esophageal motility.
62 Nutcracker esophagus 
(14.4%) was the most commonly documented esophageal mo-
tility abnormality, followed by nonspecific esophageal motor dis-Ronnie Fass and Sami R Achem
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order (10.8%). Diffuse esophageal spasm, achalasia and hyper-
tensive lower esophageal sphincter were very uncommon in this 
NCCP group. In another study, Dekel et al
63 evaluated 140 
NCCP patients using the Clinical Outcomes Research Initiative 
database. Unlike the previous study that included patients from 1 
major center with interest in esophageal motility, the study by 
Dekel et al
63 included patients from more than 60 academic, 
Veteran Affairs, and private centers from around the United 
States. The authors also found that 70% of the subjects had a nor-
mal esophageal motility test. Hypotensive lower esophageal 
sphincter (61%) was the most common motility abnormality di-
agnosed, followed by hypertensive lower esophageal sphincter, 
nonspecific esophageal motor disorder and nutcracker esophagus 
(10% each). In this study, achalasia and diffuse esophageal spasm 
were also very uncommon. The difference in the distribution of 
motility abnormalities between the 2 studies reflects the different 
study designs. In the first study, only non-GERD-related NCCP 
patients were included, whereas all newcomers were enrolled into 
the second study. A recent study from Chile evaluated 100 newly 
diagnosed NCCP patients and found that 8% of them had an ab-
normal esophageal manometry.
65 In this study, 36% of patients 
had nutcracker esophagus, 28% hypotensive lower esophageal 
sphincter, and 16% nonspecific esophageal motor disorder. The 
reason for the discrepancy between the results of this study and 
the other 2 is unclear. It appears, however, that the high rate of 
esophageal motility abnormalities recorded in NCCP patients in 
this study may reflect a local referral bias.
The relationship between NCCP and esophageal dysmotility 
remains an area of intense controversy because documentation of 
esophageal dysmotility during manometry is rarely associated 
with reports of chest pain symptoms.
2 In addition, unlike GERD 
we are still devoid of highly effective pharmacologic compounds 
that can eliminate esophageal dysmotility and thus can be used to 
demonstrate a causal relationship.
66 Furthermore, in NCCP pa-
tients who underwent simultaneous esophageal manometry and 
pH testing, chest pain was more commonly associated with acid 
reflux events than motility abnormalities.
64,67 Even the past usage 
of ambulatory 24 hour esophageal manometry was unable to im-
prove the sensitivity of the test in NCCP. In fact, studies have 
demonstrated that 27%-43% of patients did not report any chest 
pain symptoms during the test.
64,68 Moreover, the investigators 
were able to relate pain episodes to recorded esophageal dysmo-
tility in only 13%-24% of patients. Consequently, the routine us-
age of ambulatory 24 hour esophageal manometry has been ques-
tioned, and the technique is rarely performed in clinical practice. 
In 1 study, the authors were able to demonstrate improvement of 
NCCP symptoms in patients with nutcracker esophagus receiv-
ing antireflux treatment but with no effect on esophageal mo-
tility.
69
Some authorities have proposed using esophageal motility 
abnormalities in NCCP patients as a marker for an underlying 
motor disorder that may be responsible for patients’ symptoms.
70 
However, it is plausible that our current evaluative techniques of 
the esophagus provide only crude information about esophageal 
motor function. Future tests will require providing a more com-
prehensive evaluation of anatomical structure and biomechanics 
of the esophagus and their relationship to pain.
Esophageal Hypersensitivity
Esophageal hypersensitivity has been demonstrated in most 
of the non-gastroesophageal reflux disease-related noncardiac 
chest pain patients, regardless if esophageal dysmotility is 
present or absent.
Studies have consistently documented alteration in pain per-
ception regardless of whether dysmotility was present or absent in 
patients with NCCP. 
Visceral hypersensitivity is a phenomenon in which conscious 
perception of visceral stimulus is enhanced independently of the 
intensity of the stimulus.
55 Peripheral and central mechanisms 
have been proposed to be responsible for visceral hypersensitivity 
in patients with NCCP. It has been hypothesized that peripheral 
sensitization of esophageal sensory afferents leads to subsequently 
heightened responses to physiologic or pathologic stimuli of the 
esophageal mucosa.
55 Additionally, central sensitization at the 
brain level or the dorsal horn of the spinal cord may modulate af-
ferent neural function and thus enhance perception of intra-
luminal stimuli.
71 What causes peripheral or central sensitization 
remains to be determined. Studies have shown that acute tissue 
irritation results in subsequent peripheral and central sensitiza-
tion, which is manifested as increased background activity of sen-
sory neurons, lowering of nociceptive thresholds, changes in 
stimulus response curves and enlargement of receptive fields.
72 
Peripheral sensitization involves the reduction of esophageal pain 
threshold and increase in the transduction processes of primary 
afferent neurons.
73 Esophageal tissue injury, inflammation, spasm 
or repetitive mechanical stimuli can all sensitize peripheral affer-
ent nerves. The presence of esophageal hypersensitivity can be 
subsequently demonstrated long after the original stimulus is no 
longer present and the esophageal mucosa has healed. However, 
it is still unclear what factors are pivotal for the persistence of Noncardiac Chest Pain
       
117 Vol. 17, No. 2 April, 2011 (110-123)
such esophageal hypersensitivity.
Studies have demonstrated that patients with non-GERD- 
related NCCP have lower perception thresholds for pain. Richter 
et al
74 used balloon distension protocol in the distal esophagus 
and found that 50% of patients with NCCP developed pain at 
volumes of 8 mL or less in comparison with 9 mL or more in 
healthy subjects who developed pain. The authors found no dif-
ference in the pressure-volume curve of the 2 groups as well as no 
difference in esophageal motility.
74 When the balloon was in-
flated to 10 mL, patients with a history of NCCP were more like-
ly to experience pain (18/30) than the control subjects (6/30).
73 
Barish et al
73 evaluated 50 patients with NCCP and 30 healthy 
volunteers using graded balloon distension protocol. Of the pa-
tients with NCCP, 56% (28/50) experienced their “typical” chest 
pain during balloon distension as compared with 20% (6/30) of 
the normal controls.
73 Of those with NCCP who experienced 
pain, 85% reported pain at values below the usual sensory thresh-
old (20 cm H2O).
75 There was no difference in esophageal tone 
between the 2 groups. 
Rao et al
75 used impedance planimetry to evaluate 24 patients 
with NCCP and 12 healthy controls. Using balloon distention, 
they demonstrated that those with NCCP had lower perception 
thresholds for first sensation, moderate discomfort and pain in 
comparison to the healthy controls.
75 Typical chest pain was re-
produced in 83% of the NCCP patients.
75 In addition, the re-
activity of the esophagus to balloon distension was increased in 
those with NCCP, as was the pressure elastic modulus. Rao et 
al
76 also performed graded balloon distensions of the esophagus 
using impedance planimetry in 16 consecutive patients with 
NCCP (normal esophageal evaluation) and 13 healthy control 
subjects. Patients who experienced chest pain during balloon dis-
tension were subsequently restudied after receiving intravenous 
atropine. Balloon distensions reproduced chest pain at lower sen-
sory thresholds in most NCCP patients as compared with 
controls. Similar findings were documented after atropine admin-
istration despite relaxed and more deformable esophageal wall. 
Thus, the investigators concluded that hyperalgesia, rather than 
motor dysfunction, is the predominant mechanism for FCP. 
Sarkar et al
57 recruited 19 healthy volunteers and 7 patients 
with NCCP. Hydrochloric acid was infused into the distal 
esophagus during a period of 30-minute. Sensory responses to 
electrical stimulation were monitored within the acid-exposed 
distal esophagus and the non-exposed proximal esophagus both 
before and after infusion. In the healthy subjects, acid infusion in-
to the distal esophagus lowered the pain threshold in the upper 
esophagus. Patients with NCCP already had a lower resting 
esophageal pain threshold than healthy subjects. After acid perfu-
sion, their pain threshold in the proximal esophagus fell further 
and for a longer duration than in healthy subjects. Additionally, 
there was a decrease in the pain threshold of the anterior chest 
wall after acid infusion. This study demonstrated the develop-
ment of secondary allodynia (visceral hypersensitivity to in-
nocuous stimulus in normal tissue at proximity to site of tissue in-
jury) in the proximal esophagus by repeated acid exposure of the 
distal esophagus. The concurrent visceral and somatic pain hy-
persensitivity is most likely caused by central sensitization (in-
crease in excitability of spinal cord neurons induced by activation 
of nociceptive C-fibers in the area of the tissue injury). The pa-
tients with NCCP demonstrated both visceral hypersensitivity 
and amplified secondary allodynia in the esophagus. However, it 
is unclear from the study what mechanism is responsible for the 
exaggerated secondary allodynia and what initiates central sensiti-
zation in patients with NCCP. It is interesting to note that other 
studies in NCCP, using a similar human model of acute tissue ir-
ritation by acid infusion, showed no significant effect on pain 
thresholds.
77
Börjesson et al
77 also demonstrated that patients with NCCP 
have reduced sensitivity to esophageal balloon distension during 
simultaneous transcutaneous electrical nerve stimulation (TENS) 
as compared with healthy controls.
78 This further supports the 
role of visceral hypersensitivity in NCCP and suggests that the 
phenomenon is probably due to central sensitization.
79
Mehta et al
79 also demonstrated that acid infusion into the 
distal esophagus reduces esophageal pain thresholds for balloon 
distension in patients with NCCP not previously sensitive to bal-
loon distension or acid infusion.
   In 1 study, subjects underwent perfusion of the distal eso-
phagus with either normal saline or 0.1 N hydrochloric acid.
56 
Perceptual responses to intraluminal esophageal balloon dis-
tension using electronic barostat were recorded. Perfusion with 
acid was associated with a reduced sensation threshold (inno-
cuous perception) and tended to reduce the pain threshold 
(aversive sensation). The study demonstrated short-term sensiti-
zation of mechanosensitive afferent pathways by transient ex-
posure to acid. It was suggested that in patients with NCCP, acid 
reflux induces sensitization of the esophagus. This may sub-
sequently alter the way in which otherwise normal esophageal dis-
tensions are perceived.
80
Sarkar et al
80 also evaluated 14 patients with GERD-related 
NCCP and 8 healthy controls. All subjects underwent an esoph-Ronnie Fass and Sami R Achem
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ageal electrical stimulation protocol in the proximal esophagus, 
and those with NCCP demonstrated lower perception thresholds 
for pain than normal controls.
80 However, there was an increase 
in the perception thresholds for pain during electrical stimulation 
in the NCCP patients after a 6-week course of high-dose PPI 
(omeprazole 20 mg twice daily).
80 This study demonstrated that 
patients with NCCP and evidence of GERD have a component 
of esophageal hypersensitivity that is responsive to high-dose PPI 
therapy.
80
In another small study that enrolled 22 NCCP patients with 
documented nutcracker esophagus, the authors demonstrated 
that stepwise balloon distensions reproduced pain symptoms at a 
lower threshold in 90% of NCCP patients as compared with 20% 
of healthy controls.
81 It was concluded that patients with NCCP 
and nutcracker esophagus also exhibit visceral hypersensitivity. 
Additionally, visceral hypersensitivity is the likely main under-
lying mechanism for patients’ symptoms, rather than the presence 
of the high amplitude contractions (nutcracker esophagus). Un-
fortunately, the presence of GERD in these patients was not de-
termined in this study.
In a recent study, 75% of patients with FCP who underwent 
impedance planimetry demonstrated esophageal hypersensitivity.
82 
These patients had larger cross-sectional areas, decreased esoph-
ageal wall strain, distensibility, and lower thresholds for perception, 
discomfort, and pain as compared with FCP patients without 
esophageal hypersensitivity or healthy controls. Another recent 
study showed that pain evoked by bag distention in FCP patients 
is dependent primarily on stress and to a lesser degree on strain.
83 
The pain does not appear to be related to mucosal perfusion.
Psychological Comorbidity
Psychological co-morbidities, such as panic disorder, an-
xiety and depression are common in noncardiac chest 
pain patients.
Psychological comorbidity has been shown to be common in 
NCCP and affects up to 75% of patients.
84 It has yet to be de-
termined if the high level of psychological comorbidity may be re-
lated to referral bias to tertiary referral centers or if it is the result 
of long-term experience of pain. Regardless, studies reported a 
high prevalence (＞ 50%) of panic disorder, anxiety and major 
depression in NCCP patients.
20,84-97 Other psychological abnor-
malities have also been reported including neuroticism, hypo-
chondriac behavior, obsessive-compulsive disorder, phobic dis-
order, and somatization.
20,89-92,98-102 In a small study of 36 sub-
jects with NCCP, the authors found that 58% had some type of 
psychological abnormality.
103 Of those, anxiety, depression and 
panic disorder were the most common. In a large population- 
based study in Australia, the authors surveyed a random sample 
of 1,000 residents in the Sydney area.
20 Among those with 
NCCP, the prevalence of anxiety was 23% and depression 7%. In 
a telephone survey from Hong Kong that included 2,209 sub-
jects, the authors demonstrated that depression and anxiety were 
significantly more common in NCCP patients than those without 
NCCP.
93
Among all esophageal symptoms, chest pain was shown to 
closely correlate with psychometric abnormalities. In some pa-
tients, chest pain is part of a host of symptoms that characterize 
panic attack. Panic attack is a common cause for emergency room 
visits due to chest pain. In a large study that encompassed 441 
consecutive ambulatory patients presenting with chest pain to the 
emergency department of a heart center, 25% were diagnosed as 
suffering from a panic attack.
104 Whilst the reason for the ob-
served association between NCCP and panic disorder remains to 
be fully elucidated, hyperventilation was demonstrated to precip-
itate chest pain in 15% of patients with NCCP.
104 Additionally, it 
was demonstrated that hyperventilation could provoke reversible 
esophageal manometric abnormalities such as esophageal spasm 
(4%) and a nonspecific esophageal motor disorder (22%).
105 
Furthermore, studies have demonstrated that hyperventilation 
may precipitate a panic attack.
Anxiety and depression influence reports of pain and thus 
contribute to the pathophysiology of NCCP. Lantinga et al
106 
found that patients with NCCP had higher levels of neuroticism 
and psychiatric comorbidity before and after cardiac catheter-
ization than did patients with CAD. This finding appears to have 
prognostic significance because these patients display less im-
provement in pain, more frequent pain episodes, greater social 
maladjustment, and more anxiety at 1-year follow-up than in-
dividuals with relatively low initial levels of psychosocial distur-
bances. In a large epidemiological study from England, a sig-
nificant relationship between NCCP and psychiatric disorders 
was demonstrated in young adults.
107 Two independent variables 
were associated with chest pain: parental illness and fatigue dur-
ing childhood.
Studies have been inconsistent when the frequency of panic 
disorder, anxiety, and depression were compared between NCCP 
patients and those with CAD. Some studies reported increased 
panic disorder, anxiety, and depression in NCCP patients, while 
others found no significant difference in the prevalence of psy-
chological disorders between the 2 groups.
100,108-110 In 1 study of Noncardiac Chest Pain
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199 participants, panic disorder was more common in NCCP as 
compared with those with CAD (41% vs 22%).
108 However, oth-
er psychiatric disorders were highly prevalent (72%) but without 
any difference between the 2 groups. In contrast, Cormier et al
111 
demonstrated that 98 NCCP patients scored higher on measures 
of anxiety and negative life events and had a significantly greater 
prevalence of DSM III panic disorder (47% vs 6%), major de-
pression (39% vs 8%) and 2 or more simple phobias (43% vs 
12%) than did patients with CAD. In a recent multivariate analy-
sis, the authors were able to develop a predictive model for dis-
tinguishing between NCCP and CAD that includes alexithymia 
(a condition in which patients are unable to express their feelings 
with words), quality of life and coping based on religion and seek-
ing medical help (85.4% sensitivity and 80.0% specificity).
112
NCCP patients with psychological disorders show dimin-
ished quality of life, more frequent chest pain, and less treatment 
satisfaction than NCCP patients without psychological co- 
morbidity.
97 One study suggested that NCCP patients with more 
than 1 psychological disorder are more difficult to treat than those 
with a single psychological disorder.
113
Cheng et al
114 demonstrated that patients with NCCP, when 
compared to patients with rheumatism and healthy controls, 
tended to monitor more, use more problem-focused coping, dis-
play a coping pattern with a poorer strategy-situation fit and re-
ceive less emotional support in times of stress. Additionally, mon-
itoring perceptual style and problem-focused coping were asso-
ciated with higher levels of anxiety and depression. Jerlock et al
115 
evaluated 231 NCCP patients and compared their psychosocial 
profile with 1,069 healthy subjects without NCCP. The authors 
found that NCCP patients had more sleep problems, mental 
strain at work, stress at home, and negative life events as com-
pared with the healthy group.
Gender differences related to psychological factors have also 
been observed in NCCP patients. Men reported less depression 
and trait anxiety than women.
116
Conclusion
Our understanding of the epidemiology and natural course 
of NCCP remains relatively limited. Overall, the disease appears 
to be very common, without any gender predilection, and be asso-
ciated with a good prognosis. More has been learned over the 
years about GERD, esophageal dysmotility, esophageal hyper-
sensitivity and psychological comorbidity as important under-
lying mechanisms of NCCP. In patients with functional chest 
pain, the exact pathogenesis and the initial event or events that re-
sult in life-long chronic chest pain still remain poorly understood.
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